Phase III
A Phase 3, Randomized,Double-Blinded, Double-Dummy Study Evaluating the Efficacy andSafety ofEmpasiprubartVersus Intravenous Immunoglobulin in Adults With Multifocal Motor Neuropathy
- Study HIC#:2000039139
- Last Updated:03/24/2026
- Age18 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Sarah Hall
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
